United States Influenza Vaccines Market Report, Analysis and Forecast to 2025

Publisher Name :
Date: 16-Oct-2018
No. of pages: 130

"United States Influenza Vaccines market is set to touch US$ 3.5 Billion threshold by 2025.

“United States Influenza Vaccines Market Report, Analysis and Forecast to 2025” presents an in-depth assessment of the United States influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for United States influenza vaccines market. The report includes historic data from 2013 to 2017 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the united states influenza vaccines market. The report also explores detailed analysis of number of children and adults vaccinated with influenza vaccines in United States from 2013 to 2017 and forecasts to 2025. The report also details the latest information about the influenza vaccines production, supply, and allocation by major companies in United States.

A comprehensive analysis has been done on pricing, distribution & demand and effectiveness of influenza vaccines in United States. It also provides a deep and thorough evaluation of distribution channel & technique of influenza vaccination. It covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States influenza vaccines market.

The report concludes with the profiles of major players in the United States influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development of influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi TanabePharma and Biondvax Pharmaceuticals Ltd, are making novel technology-based influenza vaccines which is likely to affect the market share during the forecast period.

The major companies dominating this market for its products, services and continuous product developments are:

Seqirus, Sanofi Pasteur, GlaxoSmithKline (GSK) and AstraZeneca

The Latest Industry Data Included in this Report:


  • United States Influenza Vaccines Market Size & Analysis (2013 - 2025)

  • United States Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)

  • United States Number of Children Vaccinated with Influenza Vaccines (2013 - 2025)

  • United States Number of Adults Vaccinated with Influenza Vaccines (2013 - 2025)

  • United States Influenza Vaccines Pricing Trends & Analysis

  • United States Influenza Vaccines Production, Supply, and Allocation (By Companies)

  • United States Influenza Vaccines Distribution & Demand (2010 - 2018)

  • Effectiveness of Influenza Vaccines in United States (2004 – 2018)

  • Rapid Diagnostic Testing for the Management of Influenza

  • Distribution Channel & Technique of Influenza Vaccination in United States

  • United States Influenza Vaccines Reimbursement Policies & Regulatory System

  • Major Deals in United States Influenza Vaccines Market

  • Promising Influenza Vaccines in Clinical Development

  • Influenza Vaccines Clinical Trial Insights by Phase, Company & Country

  • Market Definition for the Specified Topic Along with Identification of Key Driver and Inhibitors for the Market

  • A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis and Recent Development


Key questions answered in this research report:


  • At what pace is the influenza vaccines market growing in United States? What will be growth trend in future?

  • How much number of persons being vaccinated with influenza vaccines during 2013 - 2025?

  • What are the key drivers and inhibitors in the current market? What will be the impact of drivers and inhibitors in the future?

  • What are the various influenza vaccines available in the United States?

  • How is the market predicted to develop in the future?

  • Who are the key players in this market space?

United States Influenza Vaccines Market Report, Analysis and Forecast to 2025

Table of Contents

1. Executive Summary

2. United States Influenza Vaccines Market Size & Analysis (2013 - 2025)

3. United States Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
3.1 Number of Children Vaccinated with Influenza Vaccines
3.2 Number of Adults Vaccinated with Influenza Vaccines

4. Key Drivers and Inhibitors of the United States Influenza Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors

5. United States Influenza Vaccines Pricing Trends & Analysis

6. United States Influenza Vaccines Production, Supply, and Allocation (By Companies)

7. United States Influenza Vaccines Distribution & Demand (2010 - 2018)

8. Effectiveness of Influenza Vaccines in United States (2004 – 2018)

9. Rapid Diagnostic Testing for the Management of Influenza

10. Distribution Channel & Technique of Influenza Vaccination in United States

11. United States Influenza Vaccines Reimbursement Policies & Regulatory System
11.1 Reimbursement Policies
11.2 Regulation System

12. Major Deals in United States Influenza Vaccines Market
12.1 Merger & Acquisitions
12.2 Collaboration Deal
12.3 Licensing Agreement
12.4 Exclusive Agreement
12.5 Distribution Agreement

13. Promising Influenza Vaccines in Clinical Development

14. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
14.1 Year 2018
14.2 Year 2017

15. Key Companies Analysis
15.1 Sanofi Pasteur
15.1.1 Business Overview
15.1.2 Influenza Vaccines Portfolio
15.1.3 Influenza Vaccine Value Sales Analysis
15.1.4 Recent Development
15.2 GlaxoSmithKline (GSK)
15.2.1 Business Overview
15.2.2 Influenza Vaccines Portfolio
15.2.3 Influenza Vaccine Sales Value Analysis
15.2.4 Recent Development
15.3 Seqirus
15.3.1 Business Overview
15.3.2 Influenza Vaccines Portfolios
15.3.3 Recent Development
15.4 AstraZeneca
15.4.1 Business Overview
15.4.2 Influenza Vaccines Portfolio
15.4.3 Influenza Vaccine Sales Value Analysis
15.4.4 Recent Development

List of Tables

Table 4–1: BiondVax Pharmaceuticals Ltd. Clinical Trials
Table 5–1: United States Pediatric Influenza Vaccines Price, 2018 – 2019
Table 5–2: United States Adult Influenza Vaccine Price, 2018 – 2019
Table 6–1: United States Influenza Vaccines Production, Supply, and Allocation
Table 7–1: Total Percentage of Influenza Vaccines Released by Week,2017 – 2018
Table 7–2: Total Percentage of Influenza Vaccines Released by Week,2016 – 2017
Table 7–3: Total Percentage of Influenza Vaccines Released by Week,2015 – 2016
Table 7–4: Total Percentage of Influenza Vaccines Released by Week,2014 – 2015
Table 8–1: Adjusted Vaccine Effectiveness Estimates for Influenza Seasons, 2004 – 2018
Table 9–1: Influenza Virus Testing Methods
Table 10–1: Distribution of Influenza Vaccination
Table 11–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 12–1: Merger & Acquisitions in Influenza Vaccines Market (Million US$),2003 – 2017
Table 12–2: Collaboration Deal in Influenza Vaccines Market,2007 – 2018
Table 12–3: Licensing Agreement in Influenza Vaccines Market,2007 – 2018
Table 12–4: Exclusive Agreement in Influenza Vaccines Market,2009 – 2016
Table 12–5: Distribution Agreement in Influenza Vaccines Market,2005 – 2016

List of Figures

Figure 2–1: United States Influenza Vaccines Market (Million US$),2013 – 2017
Figure 2–2: United States Influenza Vaccines Market Forecast (Million US$),2018 – 2025
Figure 3–1: United States Total Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2017
Figure 3–2: United States Total Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2018 – 2025
Figure 3–3: United States Number of Children Vaccinated with Influenza Vaccines (Thousand),2013 – 2017
Figure 3–4: United States Number of Children Vaccinated with Influenza Vaccines Forecast (Thousand),2018 – 2025
Figure 3–5: United States Number of Adults Vaccinated with Influenza Vaccines (Thousand),2013 – 2017
Figure 3–6: United States Number of Adults Vaccinated with Influenza Vaccines Forecast (Thousand),2018 – 2025
Figure 7–1: United States Influenza Vaccine Doses Distributed, By Season (Million),2010 – 2018
Figure 10–1: United States Place of Influenza Vaccination for Children and Adults,2017 - 2018
Figure 15–1: Sanofi Pasteur Influenza Vaccines Net Sales Value (Million US$),2013 – 2017
Figure 15–2: Sanofi Pasteur Influenza Vaccines Net Sales Value Forecast (Million US$),2018 – 2025
Figure 15–3: GSK Influenza Vaccines Net Sales Value (Million US$),2013 – 2017
Figure 15–4: GSK Influenza Vaccines Net Sales Value Forecast (Million US$),2018 – 2025
Figure 10–5: AstraZeneca Influenza Vaccines Net Sales Value (Million US$),2011 – 2015

  • Global Influenza Vaccine Market Insights, Forecast to 2025
    Published: 17-May-2019        Price: US 3900 Onwards        Pages: 120
    Influenza vaccines are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five year......
  • Global Avian Influenza Vaccines Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2024
    Published: 14-May-2019        Price: US 2600 Onwards        Pages: 154
    In this report, we analyze the Avian Influenza Vaccines industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also ......
  • Global Haemophilus B Conjugate Vaccine Industry Market Research Report
    Published: 02-May-2019        Price: US 2960 Onwards        Pages: 129
    The Haemophilus B Conjugate Vaccine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Haemophilus B Conjugate Vaccine industrial chain, this report mainly elaborates the definition, types, applications and major players of Haemophilus B Conjugate Vaccine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvan......
  • Global (United States, European Union and China) Meningococcal Vaccines Market Research Report 2019-2025
    Published: 02-May-2019        Price: US 3280 Onwards        Pages: 119
    In 2019, the market size of Meningococcal Vaccines is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Meningococcal Vaccines. This report studies the global market ......
  • Global Rubella Vaccine Industry Market Research Report
    Published: 02-May-2019        Price: US 2960 Onwards        Pages: 111
    The Rubella Vaccine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Rubella Vaccine industrial chain, this report mainly elaborates the definition, types, applications and major players of Rubella Vaccine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry developme......
  • Global Dpt Vaccine Industry Market Research Report
    Published: 02-May-2019        Price: US 2960 Onwards        Pages: 136
    The Dpt Vaccine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Dpt Vaccine industrial chain, this report mainly elaborates the definition, types, applications and major players of Dpt Vaccine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2......
  • Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025
    Published: 29-Apr-2019        Price: US 1533 Onwards        Pages: 210
    The global influenza vaccines market size is expected to surpass USD 6 billion by 2025. “Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025” presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outl......
  • Global Encephalitis Vaccination Market Data Survey Report 2013-2025
    Published: 27-Apr-2019        Price: US 1500 Onwards        Pages: 66
    Summary The global Encephalitis Vaccination market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major Application Global market size by Major Type Key manufacturers are included based on company......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Data Survey Report 2013-2025
    Published: 25-Apr-2019        Price: US 1500 Onwards        Pages: 54
    Summary The global 23-Valent Pneumococcal Polysaccharide Vaccine market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major Application Global market size by Major Type Key manufacturers are incl......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs